SCI时时刷

search
+
A Review of Heart Failure in patients with COVID-19
A Review of Heart Failure in patients with COVID-19
When caring for heart failure patients during the pandemic, all indirect and direct factors should be considered.The coron...
Cardiovascular Effects of COVID-19
Cardiovascular Effects of COVID-19
Timothy D. Henry, MD, FACC, MSCAI, EditorSantiago Garcia, MD, FACC, FSCAI, EditorEduardo Bossone, MD, PhD, FCCP, FESC, FAC...
Oxygen Therapy in Pulmonary Vascular Disease
Oxygen Therapy in Pulmonary Vascular Disease
Carta et al,19Carta A.F. Lichtblau M. Berlier C. et al.The impact of breathing hypoxic gas and oxygen on pulmonary hemodyn...
Microscopic Examination of Clots from Percutaneous Mechanical Embolectomies in Pulmonary Embolism
Microscopic Examination of Clots from Percutaneous Mechanical Embolectomies in Pulmonary Embolism
Elsevier journal websites will be undergoing maintenance on January 7th, from 8am – 11:59 UTC (3am- 7am ...
Genetics of High-Altitude Pulmonary Edema
Genetics of High-Altitude Pulmonary Edema
Bärtsch P. Mairbäurl H. Swenson E.R. et al.High altitude pulmonary oedema.Swiss Med Wkly. 2003; 133: 377-384View ...
Unusual Forms of Pulmonary Hypertension
Unusual Forms of Pulmonary Hypertension
Simonneau G. Montani D. Celermajer D.S. et al.Haemodynamic definitions and updated clinical classification of pulmonary hy...
How to Treat Right Heart Failure. Tips for Clinicians in Everyday Practice
How to Treat Right Heart Failure. Tips for Clinicians in Everyday Practice
McDonagh T.A. Metra M. Adamo M. et al.2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failu...
Cardiopulmonary Exercise Testing in Pulmonary Arterial Hypertension
Cardiopulmonary Exercise Testing in Pulmonary Arterial Hypertension
Sun X.G. Hansen J.E. Oudiz R.J. et al.Exercise pathophysiology in patients with primary pulmonary hypertension.Circulation...
Challenges in Pulmonary Hypertension
We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please v...
Impact of Hormonal-Anabolic Deficiencies in Idiopathic Pulmonary Arterial Hypertension
Impact of Hormonal-Anabolic Deficiencies in Idiopathic Pulmonary Arterial Hypertension
Galiè N. Humbert M. Vachiery J.L. et al.[2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension...
Sex- and Gender-Related Aspects in Pulmonary Hypertension
Sex- and Gender-Related Aspects in Pulmonary Hypertension
Galiè N. Humbert M. Vachiery J.L. et al.[2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension...
Mildly Elevated Pulmonary Hypertension
Mildly Elevated Pulmonary Hypertension
Department of Translational Medical Sciences, Federico II University, Naples, ItalyCenter for Basic and Clinical Immunolog...
Pregnancy and Pulmonary Hypertension
Pregnancy and Pulmonary Hypertension
Pulmonary Hypertension and Pregnancy.Obstet Gynecol. 134: 974-987George M.G. Schieb L.J. Ayala C. et al.Pulmonary hyperten...
Noncoding RNAs in Pulmonary Arterial Hypertension
Noncoding RNAs in Pulmonary Arterial Hypertension
Sommer N. Ghofrani H.A. Pak O. et al.Current and future treatments of pulmonary arterial hypertension.Br J Pharmacol. 178:...
Struggling Between Liver Transplantation and Portopulmonary Hypertension
Struggling Between Liver Transplantation and Portopulmonary Hypertension
Galie N. McLaughlin V.V. Rubin L.J. et al.An overview of the 6th world symposium on pulmonary hypertension.Eur Respir J. 5...
Use of Oral Anticoagulant Drugs in Patients with Pulmonary Hypertension
Use of Oral Anticoagulant Drugs in Patients with Pulmonary Hypertension
Demelo-Rodriguez P. Galeano-Valle F. Salzano A. et al.Pulmonary embolism: a practical guide for the busy clinician.Heart F...
Pulmonary Arterial Hypertension in Connective Tissue Diseases Beyond Systemic Sclerosis
Pulmonary Arterial Hypertension in Connective Tissue Diseases Beyond Systemic Sclerosis
Simonneau G. Montani D. Celermajer D.S. et al.Haemodynamic definitions and updated clinical classification of pulmonary hy...
Management of COVID-19 in patients with pulmonary arterial hypertension
COVID-19 Excess Mortality Collaborators. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis o...
SGLT2 Inhibitors and Peripheral Vascular Events
Song P. Rudan D. Zhu Y. et al.Global, regional, and national prevalence and risk factors for peripheral artery disease in ...
SGLT2 Inhibitors in Type 2 Diabetes Mellitus
Cardiovascular outcome trials in patients with type 2 diabetes mellitus: a major breakthroughThe Empagliflozin, Cardiovasc...
Sodium Glucose Cotransporter 2 Inhibitors, Amputation Risk, and Fracture Risk
The George Institute for Global Health, University of New South Wales, Level 5, 1 King Street, Newtown, Sydney 2042, Austr...
Sodium-Glucose Cotransporter-2 Inhibitors: Impact on Atherosclerosis and Atherosclerotic Cardiovascular Disease Events
Nelson A.J. Pagidipati N.J. Aroda V.R. et al.Incorporating SGLT2i and GLP-1RA for cardiovascular and kidney disease risk r...
Glucose-Lowering and Metabolic Effects of SGLT2 Inhibitors
Anker S.D. Butler J. Filippatos G. et al.Empagliflozin in heart failure with a preserved ejection fraction.N Engl J Med. 3...
Renoprotective Effects of SGLT2 Inhibitors
US Food and Drug Administration. Guidance for industry: diabetes mellitus — evaluating cardiovascular risk in new antidiab...
SGLT2 Inhibitors in Heart Failure
Groenewegen A. Rutten F.H. Mosterd A. et al.Epidemiology of heart failure.Eur J Heart Fail. 2020; 22: 1342-1356View ...
SGLT2 Inhibitors and Safety in Older Patients
Zinman B. Wanner C. et al.Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes.N Engl J Med. 2015; 373...
SGLT2 Inhibitors and Heart Failure with Preserved Ejection Fraction
Zinman B. Wanner C. Lachin J.M. et al.Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes.N Engl J Me...
Sodium-glucose Cotransporter 2 Inhibitors and Nonalcoholic Fatty Liver Disease
Younossi Z.M. Koenig A.B. Abdelatif D. et al.Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessm...
SGLT-2 Inhibitors
We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please v...
SGLT2 Inhibitors Are Lifesavers in Heart Failure
Ragavendra R. Baliga, MD, MBA, FACP, FRCP (Edin), FACC, EditorDeepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC, EditorEdu...
阅读更多
format_indent_increase